Published on: May 1, 2026
Categorized as: 2026 EHE 360
Clinical Trials for EHE
Michael Wagner, MD, Dana-Farber Cancer Institute; Antoine Italiano, MD, PhD, Gustave Roussy, France
2026 EHE 360 Clinical Care Summit Session 2: Clinical Trials for EHE SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic EHE Michael Wagner, MD | Dana-Farber Cancer Institute Early Insights with ODM-212, a TEAD Inhibitor, in Patients with EHE Antoine Italiano, MD, PhD | Gustave Roussy, France Recorded: May 1, 2026
